Bivalent Antibodies in Therapeutics: Past, Present and Future
Add bookmark
From bispecific antibodies and monoclonal antibodies as therapeutic agents in the past to bispecific antibodies that are said to have enormous potential to improve the therapeutic outlook for patients across the disease spectrum in the present. Read the full article here to see what the future might hold.
[inlinead]
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
